Cholinergic therapy for Down's syndrome.
Publication
, Journal Article
Kishnani, PS; Sullivan, JA; Walter, BK; Spiridigliozzi, GA; Doraiswamy, PM; Krishnan, KR
Published in: Lancet
March 27, 1999
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
March 27, 1999
Volume
353
Issue
9158
Start / End Page
1064 / 1065
Location
England
Related Subject Headings
- Treatment Outcome
- Piperidines
- Middle Aged
- Male
- Intelligence Tests
- Indans
- Humans
- General & Internal Medicine
- Female
- Drug Administration Schedule
Citation
APA
Chicago
ICMJE
MLA
NLM
Kishnani, P. S., Sullivan, J. A., Walter, B. K., Spiridigliozzi, G. A., Doraiswamy, P. M., & Krishnan, K. R. (1999). Cholinergic therapy for Down's syndrome. Lancet, 353(9158), 1064–1065. https://doi.org/10.1016/S0140-6736(98)05285-4
Kishnani, P. S., J. A. Sullivan, B. K. Walter, G. A. Spiridigliozzi, P. M. Doraiswamy, and K. R. Krishnan. “Cholinergic therapy for Down's syndrome.” Lancet 353, no. 9158 (March 27, 1999): 1064–65. https://doi.org/10.1016/S0140-6736(98)05285-4.
Kishnani PS, Sullivan JA, Walter BK, Spiridigliozzi GA, Doraiswamy PM, Krishnan KR. Cholinergic therapy for Down's syndrome. Lancet. 1999 Mar 27;353(9158):1064–5.
Kishnani, P. S., et al. “Cholinergic therapy for Down's syndrome.” Lancet, vol. 353, no. 9158, Mar. 1999, pp. 1064–65. Pubmed, doi:10.1016/S0140-6736(98)05285-4.
Kishnani PS, Sullivan JA, Walter BK, Spiridigliozzi GA, Doraiswamy PM, Krishnan KR. Cholinergic therapy for Down's syndrome. Lancet. 1999 Mar 27;353(9158):1064–1065.
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
March 27, 1999
Volume
353
Issue
9158
Start / End Page
1064 / 1065
Location
England
Related Subject Headings
- Treatment Outcome
- Piperidines
- Middle Aged
- Male
- Intelligence Tests
- Indans
- Humans
- General & Internal Medicine
- Female
- Drug Administration Schedule